(Q39351138)

English

Targeting of syndecan-1 by microRNA miR-10b promotes breast cancer cell motility and invasiveness via a Rho-GTPase- and E-cadherin-dependent mechanism.

scientific article published on 30 May 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22573479%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Targeting of syndecan-1 by microRNA miR-10b promotes breast cancer cell motility and invasiveness via a Rho-GTPase- and E-cadherin-dependent mechanism (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22573479%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

based on heuristic

inferred from title

neoplastic invasiveness

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22573479%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Sherif A Ibrahim

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22573479%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22573479%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

George W Yip

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22573479%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Christian Stock

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22573479%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Jun-Wei Pan

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22573479%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Claudia Neubauer

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22573479%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Michaela Poeter

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22573479%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Danute Pupjalis

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22573479%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Reinhard Kelsch

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22573479%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Roland Schüle

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22573479%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Ursula Rescher

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22573479%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Ludwig Kiesel

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22573479%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

language of work or name

0 references

publication date

30 May 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22573479%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

International Journal of Cancer

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22573479%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

131

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22573479%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22573479%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

E884-96

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22573479%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Therapeutic value of glycosaminoglycans in cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

Syndecan-1 expression by stromal fibroblasts promotes breast carcinoma growth in vivo and stimulates tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

Juvenile syndecan-1 null mice are protected from carcinogen-induced tumor development.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

Stromal matrix protein expression following preoperative systemic therapy in breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

Prognostic value of syndecan-1 expression in breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

Prognostic impact of syndecan-1 expression in invasive ductal breast carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

Shift of syndecan-1 expression from epithelial to stromal cells during progression of solid tumours

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

The microRNA.org resource: targets and expression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

MicroRNAs: genomics, biogenesis, mechanism, and function

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

MicroRNA gene expression deregulation in human breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

Heparin impairs angiogenesis through inhibition of microRNA-10b

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

miR-145-dependent targeting of junctional adhesion molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

Changes in heparan sulfate are associated with delayed wound repair, altered cell migration, adhesion and contractility in the galactosyltransferase I (beta4GalT-7) deficient form of Ehlers-Danlos syndrome.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

Reactive glia are recruited by highly proliferative brain metastases of breast cancer and promote tumor cell colonization

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

miRGen: a database for the study of animal microRNA genomic organization and function

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

Role of the heparan sulfate proteoglycan syndecan-1 (CD138) in delayed-type hypersensitivity.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

Gene ontology: tool for the unification of biology

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

MicroRNAs and the hallmarks of cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

Syndecan-1 in breast cancer stroma fibroblasts regulates extracellular matrix fiber organization and carcinoma cell motility

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

Role of Rho GTPases in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

Loss of RhoB expression promotes migration and invasion of human bronchial cells via activation of AKT1.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

Rho regulates p21(CIP1), cyclin D1, and checkpoint control in mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

Cdk6 blocks myeloid differentiation by interfering with Runx1 DNA binding and Runx1-C/EBPalpha interaction

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

Regulatory mechanisms controlling human E-cadherin gene expression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

Decreased platelet expression of myosin regulatory light chain polypeptide (MYL9) and other genes with platelet dysfunction and CBFA2/RUNX1 mutation: insights from platelet expression profiling

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

A RUNX/AML-binding motif residing in a novel 13-bp DNA palindrome may determine the expression of the proximal promoter of the human uPA gene

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

Transcriptional upregulation of p21/WAF/Cip1 in myeloid leukemic blasts expressing AML1-ETO.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

Syndecan-4 regulates ATF-2 transcriptional activity in a Rac1-dependent manner

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

Collagen type I induces disruption of E-cadherin-mediated cell-cell contacts and promotes proliferation of pancreatic carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

Characterization of syntenin, a syndecan-binding PDZ protein, as a component of cell adhesion sites and microfilaments

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumors

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

Targeting RhoA/Rho kinase and p21-activated kinase signaling to prevent cancer development and progression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27629

21 January 2018

Identifiers

10.1002/IJC.27629

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22573479%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

release_s4wvtglsffgkbcqpav54vy6i7q

1 reference

https://api.fatcat.wiki/v0/release/s4wvtglsffgkbcqpav54vy6i7q

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22573479%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39351138&oldid=1966905566"